Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Meta-analysis of 9 studies (3 RCTs, 6 cohorts; n=148,267) of pregnant individuals: RSVpreF vaccination vs none or placebo was associated with slightly higher hypertensive disorders of pregnancy risk (RR 1.08, 95% CI 1.02–1.13), driven by observational data; RCTs non-significant.
Meta-analysisn = 148,267
Alami et al. Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysisIn 67,624 ED presentations with suspected MI at 19 hospitals, switching from a 0/3 h to a 0/1 h troponin pathway was non-inferior for 30-day death or type 1 MI (1.1% vs 1.2%; aOR 0.93) but did not shorten ED stay (median 309 vs 309 min; p=0.65).
RCTn = 67,624 patient presentations
Boeddinghaus et al. Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trialIndividual patient data meta-analysis of 12 RCTs (32 346 HFrEF, 13 723 HFpEF): in HFrEF, baseline potassium <3.5 mmol/L was associated with higher all-cause mortality vs 4.0–4.5 (adjusted HR 1.49). Lowest risk was at 4.2–5.0 mmol/L in both HFrEF and HFpEF.
Meta-analysisn = 46,069
Ono et al. Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysisSystematic review of 7 studies (5 meta-analysed; 27,925 patients) in adults with haematological malignancy or HSCT: male sex (HR 1.34) and prior HSCT (HR 2.72) were associated with invasive yeast infection after allo-HSCT, and central venous catheters (OR 6.19) in malignancy.
Meta-analysisn = 27,925
Gras et al. Risk factors for invasive yeast infections in adult patients with hematological malignancies and/or stem cell transplant: systematic literature review and meta-analysisIn 17,095 patients after PCI for acute coronary syndrome, a default prasugrel policy did not significantly reduce 1-year death, MI or stroke vs default ticagrelor (11.1% vs 11.8%; adjusted OR 0.90, 95% CI 0.77–1.06). Major bleeding: 4.2% vs 4.4% (OR 0.80, 0.64–0.99).
RCTn = 17,095
Omerovic et al. Prasugrel versus Ticagrelor in Acute Coronary SyndromesIn 14,194 patients after acute coronary syndrome, adding milvexian 25 mg twice daily to antiplatelet therapy did not reduce CV death, MI or ischaemic stroke vs placebo (5.4% vs 5.1%; HR 1.05, 95% CI 0.91–1.21). Trial stopped for futility; severe bleeding 0.3% in both groups.
RCTn = 14,194
Gibson et al. Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome EventMeta-analysis of 17 RCTs (10 611 participants) of frozen-embryo transfer: ovulatory vs artificial endometrial preparation gave similar live-birth rates (RR 1.07, 95% CI 0.95-1.22) and non-significantly less HDP (RR 0.77, 0.55-1.07); pregnancy loss was lower (RR 0.75).
Meta-analysisn = 10,611
Martins et al. Endometrial preparation with vs without ovulation for frozen-embryo transfer: systematic review and meta-analysis of randomized controlled trialsIn 9971 adults aged ≥70 without cardiovascular disease, diabetes or dementia, atorvastatin 40 mg cut major cardiovascular events vs placebo over 5.9 years (10.9 vs 15.5/1000 person-years; HR 0.70) but did not improve disability-free survival (HR 0.94; P=0.25).
RCTn = 9,971
Zoungas et al. Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older AdultsMeta-analysis of 76 US trials (8819 participants) of psychotherapy vs inactive control for depression: race/ethnicity was unreported in 29.1%; Black participants were overrepresented and Hispanic/Latino, Asian and multiracial participants underrepresented vs state benchmarks.
Meta-analysisn = 8,819
Segre et al. Representation of racial and ethnic minorities in U.S. depression trials comparing psychotherapy vs. controls: A meta-analysis using state population benchmarksIn 80 rural Chinese village clusters (8,001 adults aged 40–80, any BP), a community- and family-based programme including salt substitute cut systolic BP by 10.7 mm Hg vs usual care at 6 months; the gap narrowed to 3.7 mm Hg at 12 months.
RCTn = 8,001
Du et al. A Coordinated Community- and Family-Based Intervention to Control Blood Pressure in Rural China: A Cluster-Randomized Trial